Log In
Print
BCIQ
Print
Print this Print this
 

Anamorelin (ONO-7643) (formerly RC-1291)

  Manage Alerts
Collapse Summary General Information
Company Helsinn Healthcare S.A.
DescriptionSmall molecule ghrelin agonist
Molecular Target Ghrelin receptor (GHSR)
Mechanism of ActionGrowth hormone secretagogue receptor (GHSR) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationCachexia
Indication DetailsTreat cachexia and anorexia in patients with advanced non-small cell lung cancer (NSCLC); Treat cachexia/anorexia in cancer patients
Regulatory Designation

Partner

Chugai Pharmaceutical Co. Ltd.; Especificos Stendhal S.A. de C.V.; Especificos Stendhal S.A. de C.V.; Gen Pharmaceuticals Inc.; Gruppo Angelini; Ono Pharmaceutical Co. Ltd.; Specialised Therapeutics Australia Pty. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today